ARCHIVES

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 18 No. 45 | November 20, 1992

Download PDF Visit The Full Archive

Related Articles

Southern Gets Two More Contracts Totaling 44.5 Million From NCI

June 14, 1974

DCT Board Approves Recompetition Of Drug Development Contracts

June 25, 1993

NCI to Advise Women in 40s o Ask Doctor About Mammography, End Routine Screening

September 24, 1993

In Brief: Pardee, Durant Head AASR, ASCO; Sartorell, Hellman Presidents Elect; ONS Reelects Johnson

May 31, 1985

Afinitor Tablet Doubles PFS; Lowers Progression Risk 65%

February 25, 2011

Ad Council, ACS Begin Ad Campaign To Promote Colon Cancer Screening.

February 1, 2002